AI assistant
Sending…
Mawson Infrastructure Group Inc. — Director's Dealing 2018
Jan 2, 2018
35202_dirs_2018-01-02_9244d037-08db-40b5-9839-545b29139bd4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Wize Pharma, Inc. (WIZP)
CIK: 0001218683
Period of Report: 2017-12-28
Reporting Person: Zarachia Yaakov (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-12-28 | Common Stock, par value $0.001 per share | P | 9289 | $0.11 | Acquired | 12292615 | Direct |
| 2017-12-29 | Common Stock, par value $0.001 per share | P | 20711 | $0.11 | Acquired | 12313326 | Direct |
More from Mawson Infrastructure Group Inc.
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
Apr 8
Regulatory Filings
2026
Apr 6
Major Shareholding Notification
2026
Mar 18
Major Shareholding Notification
2026
Feb 10
Major Shareholding Notification
2026
Feb 10
Regulatory Filings
2026
Feb 6
Proxy Solicitation & Information Statement
2026
Feb 4
Regulatory Filings
2026
Feb 2
Major Shareholding Notification
2026
Jan 30